Nephros Schedules Third Quarter 2023 Financial Results Conference Call
Nephros, Inc. will file its Q3 financial results on November 8, 2023, and host a conference call. Dial-in details provided.
Positive
Nephros, Inc. will release its Q3 financial results on November 8, 2023, potentially providing valuable insights for investors.
10/25/2023 - 07:30 AM
SOUTH ORANGE, NJ, Oct. 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its third-quarter financial results on Wednesday, November 8, 2023 after market close and will host a conference call that same day at 4:30pm ET.
Participants may dial into the call as follows:
Upon joining, please ask to be added into the Nephros conference call.
An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page .
Alternatively, a replay of the call may be accessed until November 15, 2023 at 1 (877) 344-7529 or
About Nephros
Nephros is committed to improving the human relationship with water through leading, accessible technology. We provide innovative water filtration products and services, along with water-quality education, as part of an integrated approach to water safety. Nephros goods serve the needs of customers within the healthcare and commercial markets, offering both proactive and emergency solutions for water management.
For more information about Nephros, please visit us at nephros.com .
Investor Relations Contacts:
Robert Banks, CEO
Andy Astor, Interim CFO
When will Nephros, Inc. release its Q3 financial results?
Nephros, Inc. will release its Q3 financial results on November 8, 2023.
What time is the conference call?
The conference call will take place at 4:30pm ET on November 8, 2023.
How can I access the conference call?
Participants can dial in using the following numbers: Domestic access: 1 (844) 808-7106, International access: 1 (412) 317-5285.
Will there be a replay of the conference call?
Yes, a replay of the call will be available until November 15, 2023. International callers can access the replay at 1 (877) 344-7529 or 1 (412) 317-0088, using the replay access code: 8716026.
NEPH Rankings
#361 Ranked by Stock Gains
NEPH Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Tags
Medical Specialties, Health Technology, Manufacturing, Surgical and Medical Instrument Manufacturing
About NEPH
nephros is a commercial stage medical device company that develops and sells high performance liquid purification filters. nephros filters capture contaminants as small as 5 nanometers in size; they minimize exposure to a wide variety of bacteria, viruses, fungi, parasites, and endotoxins. nephros filters use a proprietary hollow fiber technology; the hollow fiber design enables the filters to optimize the three elements critical to filter performance: • filtration – as low as 5 nanometers • flow rate – minimal disruption • filter life – up to 12 months nephros was founded in 1997, by healthcare professionals affiliated with columbia university medical center, initially to address the needs of chronic renal failure patients. the company has developed an alternative to current hemodialysis therapy known as mid-dilution hemodiafiltration (mid-hdf). nephros’ proprietary blood purification technologies enable mid-hdf to be offered to chronic renal failure patients. nephros mid-dilution fil
